Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 9.77 BATS BZX Real-Time Price As of 11:49am ET |  -0.03 / -0.31%Today’s Change | 7.09 Today|||52-Week Range 11.45 | +7.13% Year-to-Date |
Latest TEVA News | Press Releases
| Teva Pharmaceutical: Long-Term Cash Cow Nov 27 / GuruFocus News - Paid Partner Content | Exelixis (EXEL) Gains 30% YTD on Cabometyx, Pipeline Progress Nov 17 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 9.80 |
| Today’s open | 9.71 |
| Day’s range | 9.64 - 9.79 |
| Volume | 3,963,940 |
| Average volume (3 months) | 8,864,370 |
| Market cap | $10.7B |
Data as of 11:49am ET, 11/29/2023
Growth & Valuation
| Earnings growth (last year) | -660.20% |
| Earnings growth (this year) | -9.18% |
| Earnings growth (next 5 years) | +4.10% |
| Revenue growth (last year) | -5.89% |
| P/E ratio | NM |
| Price/Sales | 0.68 |
| Price/Book | 1.35 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BBIOBridgeBio Pharma Inc | -0.19 | -0.66% |
| BGNEBeigene Ltd | -0.21 | -0.11% |
| IDRSFIdorsia Ltd | 0.00 | 0.00% |
| ---- |
Data as of 11:48am ET, 11/29/2023
Financials
| Next reporting date | February 7, 2024 |
| EPS forecast (this quarter) | $0.70 |
| Annual revenue (last year) | $14.9B |
| Annual profit (last year) | -$2.4B |
| Net profit margin | -15.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Tel Aviv, Tel Aviv |
Forecasts
